Nancy Pelosi unveils an ambitious plan to lower drug prices

Putting her stamp on the health care issue that worries consumers the most, House Speaker Nancy Pelosi on Thursday unveiled an ambitious plan to lower drug prices for seniors on Medicare and younger people with private insurance. Pelosi, D-Calif., would empower Medicare to negotiate prices for the 250 costliest drugs, including insulin. Pharmaceutical companies that refuse to negotiate could face […]

Continue reading »

Oxycontin maker Purdue offers $10-12 bn for opioid claims: report

Purdue Pharma, whose prescription painkiller Oxycontin is blamed for much of the US opioid addiction epidemic, has offered $10-12 billion to settle thousands of claims against the company, NBC News reported Tuesday. The company, whose wealthy owners the Sackler family have come under international scorn for aggressively pushing the prescription drug, is in settlement talks in Cleveland, Ohio ahead of […]

Continue reading »

Cancer drug data release set to power next wave of therapeutic discovery

This week (25 July) the Genomics of Drug Sensitivity in Cancer project has released the results of four years of intense data gathering and exploration which will power genetic research into cancer treatment worldwide. The freely available data set includes unique data comparing almost 1,000 cancer cell lines’ responses to 453 licensed and experimental drugs. The project, led by researchers […]

Continue reading »

Supply of opioids predicts long-term use in injured workers

(HealthDay)—The number of days supplied of an initial opioid prescription is the strongest risk factor for developing long-term opioid use among previously opioid-free injured workers, according to a study published online July 17 in JAMA Network Open. Zoe Durand, Ph.D., from the Tennessee Department of Health in Nashville, and colleagues examined the prevalence and risk factors of long-term opioid use […]

Continue reading »

Dupixent approved for chronic rhinosinusitis with nasal polyps

Dupixent (dupilumab) has been approved to treat nasal polyps in adults with chronic rhinosinusitis, the U.S. Food and Drug Administration announced today. Dupixent, which is administered through injection, was previously approved to treat eczema in patients 12 years and older and as an add-on maintenance treatment for moderate-to-severe eosinophilic asthma or oral corticosteroid-dependent asthma. The recommended dose for adult patients […]

Continue reading »

Growing life expectancy inequality in US cannot be blamed on opioids alone

A new University of Michigan study challenges a popularized view about what’s causing the growing gap between the lifespans of more- and less-educated Americans—finding shortcomings in the widespread narrative that the United States is facing an epidemic of “despair.” Some influential studies have argued that growing life expectancy inequality is driven by so-called “deaths of despair,” suggesting that economic stagnation […]

Continue reading »

Israeli drugmaker Teva to pay Oklahoma $85 mn in opioid suit

Israeli pharmaceutical giant Teva agreed on Sunday to pay the US state of Oklahoma $85 million to settle a lawsuit accusing it of fueling the state’s opioid epidemic, Oklahoma’s attorney general said. The announcement comes after Purdue Pharma, maker of the opioid painkiller OxyContin—a key driver of the crisis responsible for tens of thousands of deaths in the United States—reached […]

Continue reading »
1 2